CD8A and laryngotracheoesophageal cleft: The present study is the first report of the identification of an immunogenic epitope of EZH2 recognized by CD4 T-cell and suggests that EZH2, which is the overexpressed TAA in LC, could be significant immunogenic target for inducing both CD4 and CD8 T-cell against LC.